Glycopyrrolate And Formoterol Fumarate has 7 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Drugs That Prolong Qtc Interval, Monoamine Oxidase Inhibitors (Maois), Diuretics. Patients taking Glycopyrrolate And Formoterol Fumarate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Major
- 2
- Moderate
- 5
Major (2)
- Glycopyrrolate And Formoterol Fumarate + Drugs That Prolong Qtc Interval— Use with extreme caution. May potentiate cardiovascular effects and increase risk of ventricular arrhythmias.
- Glycopyrrolate And Formoterol Fumarate + Monoamine Oxidase Inhibitors (Maois)— Use with extreme caution. May potentiate cardiovascular effects of formoterol.
Moderate (5)
- Glycopyrrolate And Formoterol Fumarate + Diuretics— Diuretics may potentiate hypokalemia or ECG changes with formoterol. Use with caution.
- Glycopyrrolate And Formoterol Fumarate + Nonselective Beta-Adrenergic Antagonists— Use with caution and only when medically necessary. May antagonize effects of formoterol.
- Glycopyrrolate And Formoterol Fumarate + Potassium Supplements— ECG changes and hypokalemia from these diuretics can be worsened by formoterol, especially at higher doses. Use with cau…
- Glycopyrrolate And Formoterol Fumarate + Topical Steroids— Concomitant use may potentiate hypokalemic effect of formoterol. Use with caution.
- Glycopyrrolate And Formoterol Fumarate + Xanthine Derivatives— Concomitant use may potentiate hypokalemic effect of formoterol. Use with caution.